Optimizing Bone Health in Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is an X-linked recessive disorder characterized by progressive muscle weakness, with eventual loss of ambulation and premature death. The approved therapy with corticosteroids improves muscle strength, prolongs ambulation, and maintains pulmonary function. However,...
Saved in:
Main Authors: | Jason L. Buckner, Sasigarn A. Bowden, John D. Mahan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2015/928385 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Duchenne muscular dystrophy: recent insights in brain related comorbidities
by: Cyrille Vaillend, et al.
Published: (2025-02-01) -
Prenatal Diagnosis of the Duchenne Muscular Dystrophy. A Family Presentation
by: Humberto Perera Navarro, et al.
Published: (2007-05-01) -
Unraveling the Genetic Heartbeat: Decoding Cardiac Involvement in Duchenne Muscular Dystrophy
by: Valeria Novelli, et al.
Published: (2025-01-01) -
Sugammadex and Reversal of Neuromuscular Block in Adult Patient with Duchenne Muscular Dystrophy
by: Ahmed Abdelgawwad Wefki Abdelgawwad Shousha, et al.
Published: (2014-01-01) -
A manifesting female carrier of Duchenne muscular dystrophy: importance of genetics for the dystrophinopathies
by: Zhi Xuan Quak, et al.
Published: (2023-01-01)